Join to View Full Profile
601 Elmwood Ave# 704Rochester, NY 14642
Phone+1 919-613-4077
Fax+1 919-613-4077
Dr. Dent is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Susan Dent, MD, is an oncology specialist located in Rochester, NY, with a subspecialty in breast cancer. She completed her medical education at the Michael G. DeGroote School of Medicine, graduating in 1990. Dr. Dent has contributed to various publications, including articles on cardio-oncology and cardiovascular risks associated with cancer treatment, in esteemed journals such as Cardio-Oncology and JAMA Oncology. Additionally, she serves as a principal investigator in clinical trials like STOP-HER2 and studies exploring glucagon receptor inhibition for breast cancer patients.
Education & Training
Michael G. DeGroote School of MedicineClass of 1990
Certifications & Licensure
NY State Medical License 2024 - 2027
NC State Medical License 2018 - 2024
Clinical Trials
- Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477) Start of enrollment: 2020 Nov 13
- STOP-HER2: Stopping Trastuzumab in HER2+ MBC Start of enrollment: 2023 Apr 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology ...Abdelrahman Ali, Suparna C Clasen, Anne Blaes, Stephen Casselli, Anita Deswal
Cancer Medicine. 2026-04-01 - 1 citationsGlobal disparities and future directions in cardio-oncology training: an international survey of cardiology trainees from the international cardio-oncology society.James M Wilson, Joshua Lushington, Rhys Gray, Carolina Carvalho Silva, Cristian Herrera Flores
Cardio-Oncology. 2026-01-07 - Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030).Guilherme Nader-Marta, Xiangying Chu, Satabhisa Mukhopadhyay, Vandana G Abramson, Adam Brufsky
Journal of the National Cancer Institute. 2026-01-01
Authored Content
- Highlights from SABCS 2024December 2024
- Cardio-Oncology Is a Growing Subspecialty, but Where Are the OncologistsFebruary 2024
- Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast CancerDecember 2022
Press Mentions
Five Things to Reduce Side Effects from Most Common Breast Cancer TreatmentOctober 30th, 2025- Heart Damage: The Silent Cost of Beating Breast CancerOctober 22nd, 2025
- Cancer Patients and Survivors: If Heart Health Is a Concern, Help Is AvailableFebruary 17th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
